Anagenics Ltd has released a press release.
Cellmids usa midkine patent for alopecia allowed
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Appendix 4C
- Cellmid receives australian govt grant for midkine programme
- Cellmid Updates on CxBladder License
- Cellmid receives 831K R&D tax credit
- USA launch of evolis
Later from Anagenics
- Midkine alopecia patent european allowance
- Cellmid: Appendix 4D and Half Year Accounts
- Cellmid: to Refinance R&D Loan Facility
- Cellmids FGF5 inhibitor clinical study published
- Nature Paper MK in Melanoma
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics